TherapeuticsMD (TXMD) Operating Margin (QoQ) (2011 - 2026)
TherapeuticsMD (TXMD) Operating Margin (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.69 Bn | 40.04 Bn | 2.15 Bn |
| 3 | Zoetis | 32.27 Bn | 30.60 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.99 Bn | 19.33 Bn | 683.80 Mn |
| 6 | Viatris | 18.93 Bn | 18.04 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.59 Bn | 15.20 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | TherapeuticsMD | 23.96 Mn | 14.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 596.00 |
| Mar 31, 2026 | 7,393.00 |
| Dec 31, 2025 | -6,385.00 |
| Sep 30, 2025 | -3,694.00 |
| Jun 30, 2025 | 25,295.00 |
| Mar 31, 2025 | -22,820.00 |
| Dec 31, 2024 | 10,956.00 |
| Sep 30, 2024 | 98,457.00 |
| Jun 30, 2024 | -82,702.00 |
| Mar 31, 2024 | -2,136.00 |
| Dec 31, 2023 | 300,179.00 |
| Sep 30, 2023 | -277,961.00 |
| Jun 30, 2023 | 7,543.00 |
| Mar 31, 2023 | -71,176.00 |
| Dec 31, 2022 | 417,206.00 |
| Sep 30, 2022 | 16,784.00 |
| Jun 30, 2022 | -169,731.00 |
| Mar 31, 2022 | -238,246.00 |
| Dec 31, 2021 | -3,235.00 |
| Sep 30, 2021 | -419.00 |